Table 2 Clinical characteristics of psychiatric patients with psychoactive substance use and seroprevalence of T. gondii infection

Patient group

 Inpatients

98

12

12.2

0.22

 Outpatients

51

3

5.9

Psychiatric diagnosis

 F10 (use of alcohol)

38

3

7.9

0.89

 F12 (use of cannabinoids)

8

1

12.5

 F13 (use of sedative hypnotics)

7

1

14.3

 F14 (use of cocaine)

1

0

0.0

 F15 (use of other stimulants, caffeine)

3

1

33.3

 F17 (use of tobacco)

10

1

10.0

 F19 (use of multiple drugs)

82

8

9.8

Subtype of disorder

 F1x.0 (acute intoxication)

2

0

0.0

0.87

 F1x.1 (harmful use)

28

2

7.1

 F1x.2 (dependence syndrome)

118

13

11.0

 F1x.5 (psychotic disorder)

1

0

0.0

Evolution time

 <10 years

79

7

8.9

0.8

 10-20 years

48

5

10.4

 >20 years

22

3

13.6

Response to treatment

 Good

85

8

9.4

0.93

 Regular

53

6

11.3

 Bad

11

1

9.1

Other psychiatric disease

 Yes

77

10

13.0

0.22

 No

72

5

6.9

Aggressiveness

 Yes

99

6

6.1

0.02

 No

50

9

18.0

Suicide ideation

 Yes

99

5

5.1

0.004

 No

50

10

20.0

Suicide attempt

 Yes

57

2

3.5

0.03

 No

92

13

14.1

Number of suicide attempts

 1-3

45

2

4.4

1

 >3

12

0

0.0

Time of last suicide attempt

 <6 months ago

26

1

3.8

1

 ≥6 months ago

31

1

3.2